🇺🇸 FDA
Company

XTL

XTL BIOPHARMACEUTICALS LTD

XTLB biotech USA

Quick answer

XTL is a biotech company (XTLB) headquartered in NEW YORK, NY, USA with 4 tracked pipeline programs.

Pipeline (4)

project

Bicifadine

Chronic Peripheral Neuropathy Pain in Diabetics

Phase 2 · small_molecule · terminated

1 trials project

Bicifadine

Diabetic Peripheral Neuropathy

Phase 2 · small_molecule · active

1 trials project

XTL 6865

Hepatitis C

Phase 1 · small_molecule · active

1 trials project

XTL-2125

Chronic Hepatitis C Virus Infection

Phase 1 · small_molecule · terminated

1 trials

Patents (7)

patent

US 8329703

Pyrazole compounds

Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8143276

4-thio substituted quinoline and naphthyridine compounds

Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8048889

3,4-disubstituted coumarin and quinolone compounds

Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 7994360

Benzofuran compounds

Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 7923004

4-ethynyl pyrazole derivative compounds and methods for treatment of HCV

Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 6254867

Human monoclonal antibodies to the hepatitis B surface antigen

Expires Mon Jun 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 6146629

Human monoclonal antibody against Hepatitis B virus surface antigen (HBVsAg)

Expires Mon Nov 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)